Growth hormone (GH) research has long been a cornerstone of endocrinology, but interest has increasingly shifted from exogenous HGH administration toward compounds that stimulate the body’s own pituitary output. Among the most widely studied combinations in this space is CJC-1295 (No DAC) paired with Ipamorelin — two peptides that work through distinct but complementary mechanisms.
How They Work Individually
CJC-1295 without DAC (also known as Modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone (GHRH). It binds to GHRH receptors in the pituitary gland, triggering the release of growth hormone in a manner that mimics the body’s natural signaling. Its half-life of approximately 30 minutes supports pulsatile GH release patterns — more physiologically representative than longer-acting GHRH analogs.
Ipamorelin is a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R1a) in the pituitary. What makes Ipamorelin particularly notable in research is its selectivity — it stimulates GH release without significantly elevating cortisol, prolactin, or ACTH, side effects that are more commonly associated with other peptides in this class such as GHRP-2 or GHRP-6.
The Case for Combining Them
The combination works because CJC-1295 (No DAC) and Ipamorelin act on two separate receptor systems — GHRH receptors and ghrelin receptors — that have synergistic effects on GH output. When activated together, the pituitary response is amplified beyond what either peptide achieves alone. Research in animal models has shown substantially greater GH pulse amplitude when both pathways are stimulated simultaneously.
This synergistic mechanism has made the combination one of the most referenced pairings in GH secretagogue research literature.
Practical Research Considerations
Both peptides are supplied in lyophilized form and reconstituted with bacteriostatic water. Storage at 2-8°C prior to reconstitution is recommended to preserve full biological potency. Pure Peptides supplies both individually and as a pre-formulated 10mg combination blend (CJC-1295 No DAC 5mg + Ipamorelin 5mg) for researchers studying GH secretion dynamics.
Our entire GH secretagogue catalog — including Sermorelin, Tesamorelin, GHRP-2, GHRP-6, Hexarelin, and HGH — is independently HPLC-verified and cold-chain shipped to your laboratory.
⚠️ All products are intended strictly for laboratory and in-vitro research purposes only. Not approved for human or veterinary use.